A Review on Liposome-Based Therapeutic Approaches Against Malignant Melanoma Publisher Pubmed



Mirzavi F¹ ; Barati M² ; Soleimani A¹ ; Vakilighartavol R³ ; Jaafari MR^{4, 5} ; Soukhtanloo M^{1, 6}
Source: International Journal of Pharmaceutics Published:2021

Abstract

Melanoma is a highly aggressive form of skin cancer with a very poor prognosis and excessive resistance to current conventional treatments. Recently, the application of the liposomal delivery system in the management of skin melanoma has been widely investigated. Liposomal nanocarriers are biocompatible and less toxic to host cells, enabling the efficient and safe delivery of different therapeutic agents into the tumor site and further promoting their antitumor activities. Therefore, the liposomal delivery system effectively increases the success of current melanoma therapies and overcomes resistance. In this review, we present an overview of liposome-based targeted drug delivery methods and highlight recent advances towards the development of liposome-based carriers for therapeutic genes. We also discuss the new insights regarding the efficacy and clinical significance of combinatorial treatment of liposomal formulations with immunotherapy and conventional therapies in melanoma patients for a better understanding and successfully managing cancer. © 2021 Elsevier B.V.